InvestSMART

Arbitr Group Limited (ASX: AGT) - Announcements

- Current share price for AGT : $0.130

ASX company news and announcements for Arbitr Group Limited (AGT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Arbitr Group Limited (AGT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Arbitr Group Limited (AGT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Arbitr Group Limited (AGT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$8 Notice of Annual General Meeting/Proxy Form 2 Oct 2026 10:08AM $0.125 $0.130 risen by 4%
$8 Change of Company Name and ASX Code 29 Sep 2026 9:22AM n/a $0.130 n/a
$8 Positive Results for Anti-Cancer Clinical Trial 9 Jun 2004 8:30AM $0.490 $0.130 fallen by 73.47%
$8 Cross Border Merger with ChemGenex Therapeutics 27 Apr 2004 9:26AM $0.560 $0.130 fallen by 76.79%
$8 Accepted into Federal Gov. Pharmaceuticals Partnership Prog. 23 Apr 2004 4:09PM $0.520 $0.130 fallen by 75%
$8 Accepted into Federal Gov. Pharmaceuticals Partnership Prog. 23 Apr 2004 4:09PM $0.520 $0.130 fallen by 75%
$8 Half Yearly Report & Half Year Accounts 27 Feb 2004 10:15AM $0.485 $0.130 fallen by 73.20%
$8 Patents novel targets for over the counter obesity therapies 4 Feb 2004 9:28AM $0.560 $0.130 fallen by 76.79%
$8 Patents novel targets for over the counter obesity therapies 4 Feb 2004 9:28AM $0.560 $0.130 fallen by 76.79%
$8 AGT Biosciences Researches Attract NH & MRC Funding 22 Jan 2004 9:45AM $0.470 $0.130 fallen by 72.34%
$8 AGT Biosciences Researches Attract NH & MRC Funding 22 Jan 2004 9:45AM $0.470 $0.130 fallen by 72.34%
$8 Clinches major collaboration with US Company 20 Nov 2003 9:36AM $0.520 $0.130 fallen by 75%
$8 Clinches major collaboration with US Company 20 Nov 2003 9:36AM $0.520 $0.130 fallen by 75%
$8 Patent Protected Gene has Implications in Multiple Diseases 29 Sep 2003 9:33AM $0.610 $0.130 fallen by 78.69%
$8 Patent Protected Gene has Implications in Multiple Diseases 29 Sep 2003 9:33AM $0.610 $0.130 fallen by 78.69%
$8 AGT&SPL ann collaboration to dev new drug therapies 18 Sep 2003 9:51AM $0.590 $0.130 fallen by 77.97%
$8 Preliminary Final Report 10 Sep 2003 5:37PM $0.640 $0.130 fallen by 79.69%
$8 Major new finding in Diabetes 25 Aug 2003 9:43AM $0.620 $0.130 fallen by 79.03%
$8 Patent protected gene has major impl in cancer & ageing 19 Aug 2003 8:59AM $0.350 $0.130 fallen by 62.86%
$8 Announces patenting of three new obesity & diabetes genes 16 Jul 2003 10:32AM $0.295 $0.130 fallen by 55.93%
$8 AGT Biosciences Genomics Strengths Recognised by USA NIH 3 Jul 2003 10:57AM $0.285 $0.130 fallen by 54.39%
  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.